These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 224109)

  • 41. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K; Witter RL; Lee LF; Yanagida N
    Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adaptation of Marek's disease virus to the Vero continuous cell line.
    Jaikumar D; Read KM; Tannock GA
    Vet Microbiol; 2001 Mar; 79(1):75-82. PubMed ID: 11230930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Avian cell cultures grown in an open system (dishes) without CO2 incubator, and their use for virus cultivation.
    Cho BR
    Avian Dis; 1976; 20(4):756-60. PubMed ID: 186014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro biological differences between the pathogenic and the apathogenic Marek's disease herpesvirus.
    Cho BR
    Avian Dis; 1976; 20(2):242-52. PubMed ID: 180957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of in vitro adaptation of Marek's disease virus on pock induction on the chorioallantoic membrane of embryonated chicken eggs.
    Sharma JM; Coulson BD; Young E
    Infect Immun; 1976 Jan; 13(1):292-5. PubMed ID: 175018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of Marek's Disease Virus Infection by Toll-Like Receptor Ligands in Chicken Embryo Fibroblast Cells.
    Bavananthasivam J; Kulkarni RR; Read L; Sharif S
    Viral Immunol; 2018 Jun; 31(5):389-396. PubMed ID: 29570417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintenance of Marek's disease herpesvirus latency in vitro by a factor found in conditioned medium.
    Buscaglia C; Calnek BW
    J Gen Virol; 1988 Nov; 69 ( Pt 11)():2809-18. PubMed ID: 2460584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen.
    Glaubiger C; Nazerian K; Velicer LF
    J Virol; 1983 Mar; 45(3):1228-34. PubMed ID: 6300460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells.
    Tischer BK; Schumacher D; Messerle M; Wagner M; Osterrieder N
    J Gen Virol; 2002 May; 83(Pt 5):997-1003. PubMed ID: 11961253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo and in vitro infections of chicken lymphocytes with Marek's disease virus or herpesvirus of turkeys.
    Kirisawa R; Mikami T
    Nihon Juigaku Zasshi; 1983 Dec; 45(6):727-38. PubMed ID: 6323800
    [No Abstract]   [Full Text] [Related]  

  • 51. Toll-like receptor 3 pathway restricts Marek's disease virus infection.
    Zou H; Su R; Ruan J; Shao H; Qian K; Ye J; Qin A
    Oncotarget; 2017 Sep; 8(41):70847-70853. PubMed ID: 29050325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of non-oncogenic Marek's disease virus-infected and turkey herpesvirus-infected lymphocytes.
    Shek WR; Schat KA; Calnek BW
    J Gen Virol; 1982 Dec; 63(2):333-41. PubMed ID: 6296281
    [No Abstract]   [Full Text] [Related]  

  • 53. Properties of the DNA polymerase induced by Marek's disease herpesvirus, strain GA, upon infection of duck embryo fibroblasts.
    Boezi JA; Lee LF; Towle HC; Blakesley RW; Burmester BR
    IARC Sci Publ (1971); 1975; (11 Pt 1):91-5. PubMed ID: 190161
    [No Abstract]   [Full Text] [Related]  

  • 54. Multiplication of turkey herpes virus and Marek's disease virus in chick embryo skin cell cultures.
    Prasad LB; Spradbrow PB
    J Comp Pathol; 1977 Oct; 87(4):515-20. PubMed ID: 201676
    [No Abstract]   [Full Text] [Related]  

  • 55. Molecular-biological characterization of Marek's disease virus. I. Identification of virus-specific polypeptides in infected cells.
    Van Zaane D; Brinkhof JM; Westenbrink F; Gielkens AL
    Virology; 1982 Aug; 121(1):116-32. PubMed ID: 6287716
    [No Abstract]   [Full Text] [Related]  

  • 56. Heterogeneous population of virus DNA in serially passaged Marek's disease virus preparation.
    Tanaka A; Lee YS; Nonoyama M
    Virology; 1980 Jun; 103(2):510-13. PubMed ID: 6247828
    [No Abstract]   [Full Text] [Related]  

  • 57. Bioassay of local Mareks disease agent in cell culture.
    Waseem M; Pathak RC; Singh DP
    Indian J Exp Biol; 1976 May; 14(3):333-6. PubMed ID: 186402
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on the etiology of Marek's disease. I. Propagation of the agent in cell culture.
    Solomon JJ; Witter RL; Nazerian K; Burmester BR
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):173-7. PubMed ID: 5644639
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of verious disinfectants on dust-borne Marek's disease virus].
    Jurajda V
    Vet Med (Praha); 1977 Nov; 22(11):687-92. PubMed ID: 203082
    [No Abstract]   [Full Text] [Related]  

  • 60. Marek's Disease Herpesviruses I. Production and Preliminary Characterization of Marek's Disease Herpesvirus A Antigen.
    Long PA; Kaveh-Yamini P; Velicer LF
    J Virol; 1975 May; 15(5):1182-91. PubMed ID: 16789152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.